Bladder cancer chemotherapy studies supported by the National Bladder Cancer Project.
The collaborative group chemotherapy studies of the National Bladder Cancer Project are summarized with regard to intravesical and systemic agents. The necessity for longitudinal observations and data collection in all cases of bladder cancer, and not just those receiving chemotherapy, is also stressed.
D000328:Adult; D000609:Aminoacridines / Q000008:administration & dosage; D000677:Amsacrine; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002278:Carcinoma in Situ / Q000188:drug therapy / Q000401:mortality; D002291:Carcinoma, Papillary / Q000188:drug therapy / Q000401:mortality; D002945:Cisplatin / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D006801:Humans; D015474:Isotretinoin; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D009096:Multi-Institutional Systems; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D013852:Thiotepa / Q000008:administration & dosage; D014212:Tretinoin / Q000008:administration & dosage; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000401:mortality
D000609:Aminoacridines; D000970:Antineoplastic Agents; D008937:Mitomycins; D000677:Amsacrine; D016685:Mitomycin; D014212:Tretinoin; D013852:Thiotepa; D015474:Isotretinoin; D002945:Cisplatin